Dr. Wolff Licenses Tripeptide to China’s Link Health

German pharmaceutical company Dr. Wolff Group has agreed to license its new tripeptide substance, KdPT, to China’s Link Health for further development. The tripeptide has shown very good results for several inflammatory conditions.

The license gives the Guangzhou-based company the exclusive right to develop and market KdPT in China, Hong Kong, Taiwan and Macao. Link Health will perform and finance the entire clinical development of KdPT in China for all inflammatory conditions, including ulcerative colitis, Crohn’s disease, psoriasis and others.

Before it is approved by the Chinese State Food and Drug Administration (CSFDA), further clinical trials must be conducted in China as well.

Dr. Wolff will receive a series of payments worth millions over several years, depending on the stage of development and the status of approval for various indications. Christoph Abels, Dr. Wolff’s medical director, said the company decided to out-license KdPT as inflammatory bowel disease was not one of its core areas for development.

KdPT is said to act very quickly – significant improvement is apparent after only two weeks with maximum effect achieved after six weeks. The treatment is most effective in patients who have already been treated with standard therapies and steroids.

Dr. Wolff said since around 40% of patients do not respond adequately to standard treatment, there was an urgent need for a drug to close the gap between the usual therapies and cortisone or immunosuppressants.

Interview

Specialty Chemicals in a Shifting World
Adapting to Tariffs and Strengthening Regional Networks

Specialty Chemicals in a Shifting World

Jennifer Abril, President & CEO of SOCMA, discusses the impact of new tariffs and the importance of regional supply networks in the specialty chemical industry.

CHEManager Spotlight

Standardization and Harmonization of Digital Chemical and Pharmaceutical Logistics
Creating Interfaces

Standardization and Harmonization of Digital Chemical and Pharmaceutical Logistics

CHEManager Spotlight is an exclusive event tailored for practitioners and decision-makers in the chemical industry. This part of our event series delves into the latest trends and innovations in logistics to streamline your operations and drive efficiency.